{
    "code": 0,
    "data": [
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Outcome of Board meeting dated 6th February 2026 for change in management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b44d5c6-3910-4cbc-8cfc-a9eb96e6a29b.pdf",
            "news_date": "2026-02-06 14:58:28"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th February 2026",
            "news_body": "Outcome of Board meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=975fbfd4-711f-48dd-b1dc-4cb4cb02d207.pdf",
            "news_date": "2026-02-06 14:55:43"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve Appointment Of Chief Financial Officer Of The Company And Any Other Businesses.",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Board meeting to be held on 6th February 2026 to consider and approve appointment of Chief Financial Officer of the Company and any other Businesses.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88452f5f-678b-4dc5-ab8a-69be6d66466e.pdf",
            "news_date": "2026-02-04 18:16:35"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Disclosure of change in credit rating as received from CRISIL",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01996188-b0be-438a-81ad-ebda8498c809.pdf",
            "news_date": "2026-02-03 17:35:33"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Disclosure Pursuant to Regulation 30 Schedule III Part A Para 7(B) of SEBI(LODR) Regulations 2015 for resignation of Mr. Rukmesh P. Dhandhania -Independent Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46a5eea8-e091-485f-ac88-1f575920f51a.pdf",
            "news_date": "2026-01-17 16:24:22"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Pursuant to Regulation 30 Schedule III Part A Para A(7B) Intimation of resignation of Shri Rukmesh P. Dhandhania- Independent Director of the Company w.e.f. 16th January 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db304b0b-d8c9-4df2-98bf-e434697f4119.pdf",
            "news_date": "2026-01-17 16:11:12"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of Newspaper publication for declaration of Un-Audited Financial Results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b808e674-22aa-494c-a247-f403794c898b.pdf",
            "news_date": "2026-01-16 16:38:38"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Acceptance of resignation tendered by Ajay Avinash Samant- Chief Financial Officer of the Company effective from 31st January 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5af6f28-65d8-424c-8f9b-6beb0df5e4fa.pdf",
            "news_date": "2026-01-15 19:24:56"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Outcome of Board meeting held on 15th January 2026 for declaration of Un-Audited Financial results of the Company for the quarter ended 31st December 2025",
            "news_id": "47f6d2c1-824b-4578-847e-b09b48d202b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e761af5-adeb-4ec6-9b55-862f26c2d29f.pdf",
            "news_date": "2026-01-15 18:00:09",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Outcome of Board meeting held on 15th January 2026 for declaration of Un-Audited Financial results of the Company for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e761af5-adeb-4ec6-9b55-862f26c2d29f.pdf",
            "news_date": "2026-01-15 18:00:09"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting  Held On 15Th January 2026 Inter Alia To Approve Un-Audited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Outcome of Board Meeting  held on 15th January 2026 inter alia to approve un-audited Financial Results for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0f023a-e17d-41ff-9047-8cb917883822.pdf",
            "news_date": "2026-01-15 17:36:52"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=470c22b9-cc20-4a04-a757-dd1201f0d61a.pdf",
            "news_date": "2026-01-12 18:13:52"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025.",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 15th January 2026 for declaration of Un-Audited Financial Results for the quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a5ad2e1-89f3-4d56-942b-8a67b1cabb11.pdf",
            "news_date": "2026-01-07 17:07:22"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revert To The Query Raised By BSE Surveillance Department Dated 5Th January 2026 Regarding Clarification In Price Movement.",
            "news_body": "Clarification for the query raised by Surveillance Department of BSE Limited dated 5th January2026 regarding Movement in price of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdc20e51-8fc1-4d82-b45a-528d4c674096.pdf",
            "news_date": "2026-01-07 12:04:54"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Mangalam Drugs & Organics Ltd",
            "news_body": "The Exchange has sought clarification from Mangalam Drugs & Organics Ltd on January 5 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-01-05 19:00:47"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window from January 1 2026 till the expiry of Forty-eight (48) hours after the declaration of Un- Audited Financial Results for the period ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=281d21fa-2397-408e-b33b-83145d453fec.pdf",
            "news_date": "2026-01-01 16:53:19"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Explanation To The Intimation Filed On 29Th March 2025 Regarding Resignation Of Chief Financial Officer Of The Company.",
            "news_body": "Explanation to the intimation filed on 29th March 2025 regarding reasoning for the resignation of Chief Financial Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5734dcd4-f6d4-4ff6-b302-7eb5bf2dab01.pdf",
            "news_date": "2025-12-24 17:16:31"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Intimation of repeat international order clients amounting to approx 15 Crores.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2254167-84be-43c6-86b2-b5e20a956b7c.pdf",
            "news_date": "2025-11-25 16:10:35"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for declaration of Un-Audited Financial results (Standalone and Consolidated) for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bef5104d-7877-472d-961b-9c9cea808e7a.pdf",
            "news_date": "2025-11-21 15:15:57"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Board meeting held on 20th September 2025 to approve un-audited Financial results of the Company for the quarter ended 30th September 2025",
            "news_id": "c00e30e4-bd88-4962-8bff-a488777fe7d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79504818-5127-47b5-b291-137999507c8c.pdf",
            "news_date": "2025-11-20 20:13:04",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Board meeting held on 20th September 2025 to approve un-audited Financial results of the Company for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79504818-5127-47b5-b291-137999507c8c.pdf",
            "news_date": "2025-11-20 20:13:04"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 20Th November 2025 At 12:00 P.M. To Approve Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Intimation of outcome of Board meeting held on 20th November 2025 at 12:00 p.m. to approve standalone and consolidated un-audited financial results of the Company for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9daf6c27-e1f7-4e70-975c-f2509c3202ac.pdf",
            "news_date": "2025-11-20 19:55:12"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Defaults under Para A sub-paragraph 6 of Schedule ",
            "descriptor": "GENERAL",
            "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Initial Disclosure",
            "news_body": "This is with reference to disclosure of default by a listed Entity on non-payment of the interest or principal amount in full on the date when the debt has become due and payable. Intimation is regarding the Company making declaration that the company has defaulted on its loan obligation to the bank of Baroda and Bank of Maharashtra for a period exceeding 30  days on a continous basis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2cfc70-a00e-4736-a0a9-049c6e10b699.pdf",
            "news_date": "2025-11-18 15:35:15"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Delay in Financial Results",
            "news_body": "Intimation regarding delay in declaration of Financial results of the Company for the quarter ended 30th September 2025.",
            "news_id": "f2a5244e-40a9-4fd2-9e2d-2e56f11ae294",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=191e47b8-834f-4583-ba6c-3d55c9144f7e.pdf",
            "news_date": "2025-11-13 18:44:23",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Delay in Financial Results",
            "descriptor": "Financial Results",
            "caption": "Results-Delay in Financial Results",
            "news_body": "Intimation regarding delay in declaration of Financial results of the Company for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=191e47b8-834f-4583-ba6c-3d55c9144f7e.pdf",
            "news_date": "2025-11-13 18:44:23"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting Rescheduled",
            "caption": "Board Meeting Intimation for Postponement Of Board Meeting  To Be Held On 20Th November 2025",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/11/2025 inter alia to consider and approve Intimation of postponement of Board meeting originally to be held on 13th November 2025 is re-scheduled for 20th November 2025 due to unavoidable circumstances.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0573416a-da70-4928-93dc-4e259913b974.pdf",
            "news_date": "2025-11-13 15:03:28"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 11 2025 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F570516D_25AA_406B_A9AC_177D3BF7E996_180255.pdf",
            "news_date": "2025-11-11 18:02:58"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 13Th November 2025 To Consider And Approve Un-Audited Financial Results(Standalone And Consolidated) For The Quarter Ended 30Th September 2025.",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Intimation of Board meeting to be held on Thursday 13th November 2025 to consider and approve Un-audited Financial Results (Standalone & Consolidated)for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ed716d2-634d-4137-98b6-a3ebc22ed31a.pdf",
            "news_date": "2025-11-05 18:20:21"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copies of Newspaper Advertisements for Intimation of final hearing at Honble NCLT Hearing and Invitation for Representations- Scheme of merger under Section 230-232 of the Companies Act 2013 in the matter of Mangalam Drugs and Organics Limited Approving the scheme of Merger by Absorption of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited with  Mangalam Drugs and Organics Limited  under Section 230 to 232 of Companies Act 2013 being convened as per the Orders of the Honble National Company Law Tribunal Mumbai Bench(NCLT)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5afdf1bf-6b83-4b8b-bec2-2c852ec79186.pdf",
            "news_date": "2025-10-16 16:53:52"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Intimation of CTC of Order copy for C.P. (CAA)210(MB)/2025 NCLT hearing dated 23rd September 2025 on the matter of merger under Section 230 to 232 of Companies Act 2013 for final hearing dated 16th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccb985eb-0cda-43ac-8ce3-2373a57f01e0.pdf",
            "news_date": "2025-10-15 15:34:20"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Intimation of CTC of Order copy for C.P. (CAA)210(MB)/2025 NCLT hearing dated 23rd September 2025 on the matter of merger under Section 230 to 232 of Companies Act 2013 for final hearing dated 16th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99c64f26-69ec-41fc-8eab-e0ec3be1d0f9.pdf",
            "news_date": "2025-10-15 15:32:51"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 received from MUFG Intime India Private Limited (RTA) for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2ef8f9d-ef35-4da9-8024-1f43cf3388dc.pdf",
            "news_date": "2025-10-10 11:44:14"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Submission of Scrutinizers Report along with the Voting results for the resolutions passed by the shareholders of the Company at 52nd Annual General Meeting of the Company held on 29th September 2025 at 3: 00PM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0767a82f-f5ee-438a-ae1f-8cafb0708f60.pdf",
            "news_date": "2025-10-01 15:28:39"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of  M/s Ragini Chokshi & Co. Secretarial Auditor of the Company for the period of 5 years commencing from 1st April 2025 to 31st March 2030",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c04c807e-831a-47be-9c94-9834a30508fd.pdf",
            "news_date": "2025-09-30 18:31:55"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window from 1st October 2025 till declaration of Un-audited Financial Results for the Period ending September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90742e01-1957-452f-bb2f-69fdd4e9e698.pdf",
            "news_date": "2025-09-30 13:20:33"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Summary proceedings of the Annual General meeting of Mangalam Drugs and Organics Limited held on 29th September 2025 t 3:00 p.m.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2e006f5-b435-47f3-a0e4-866a16608b81.pdf",
            "news_date": "2025-09-29 18:47:52"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for Corrigendum to 52nd Annual Report for F.Y.2024-25 in Financial Express in English Language and in Loksatta Vernacular Language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=427ca34c-215e-4bd3-92f4-b9790fc72a55.pdf",
            "news_date": "2025-09-19 15:50:49"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI(LODR)Regulations 2015 For Submission Of Corrigendum For 52Nd Annual Report Of 2024-25.",
            "news_body": "Announcement under Regulation 30 of SEBI(LODR) Regulations 2015 for submission of Corrigendum for 52nd Annual Report of 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cc20f14-ca95-4df5-8917-d05b70180b22.pdf",
            "news_date": "2025-09-19 15:03:35"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Submission of 52nd Annual Report of the Company including Notice of 52nd Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3276e954-e3b2-440f-9ba2-f844750d1d41.pdf",
            "news_date": "2025-09-10 17:36:35"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of 52nd Annual General Meeting of the Company to be held on 29th September 2025 at 3:00 p.m. in Financial Express (English daily) and Loksatta (Marathi daily)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d8ddd26-68b8-426f-95d4-511292cd150a.pdf",
            "news_date": "2025-09-09 17:47:57"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of 52Nd Annual General Meeting Of The Company To Be Held On 29Th September 2025 At 3:00 P.M. Through Video Conferencing/ Other Audio Visual Means.",
            "news_body": "Intimation of 52nd Annual General meeting of the Company to be held on 29th September 2025 at 3:00 p.m. through video conferencing/ other Audio Visual means.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d564b61-35b3-4301-8c0e-55a2e3874c0a.pdf",
            "news_date": "2025-09-07 16:28:48"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Submission of 52nd Annual Report including notice of 52nd Annual General meeting (AGM) of the Company for the F.Y.2024-25 and intimation of cut off date for remote e-voting for the AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aac0943e-bf1d-456a-b8e9-d553da964c73.pdf",
            "news_date": "2025-09-07 16:15:39"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Ragini Chokshi & Co. As Secretarial Auditor Of The Company For The Period Of 5 Years Commencing From 1St April 2025 Till 31St March 2030 Subject To Approval Of Shareholders.",
            "news_body": "Outcome of Board meeting held on 5th September 2025 for appointment of Ragini Chokshi & Co. as Secretarial Auditor of the Company for the period of 5 years commencing from 1st April 2025 till 31st March 2030 subject to approval of shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af703a95-36ef-4b08-8a3e-50f6c67529d6.pdf",
            "news_date": "2025-09-05 21:02:27"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th Sepetember 2025 For Appointment Of Secretarial Auditor Appointment For A Period Of Five Years Subject To Approval Of Shareholders In The Upcoming Annual General Meeting.",
            "news_body": "Outcome of Board Meeting held on 5th Sepetember 2025 for Appointment of Secretarial Auditor appointment for a period of five years subject to Approval of Shareholders in the upcoming Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47667633-f9e6-4727-98a0-b091780da2ba.pdf",
            "news_date": "2025-09-05 18:45:00"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting  Intimation To Be Held On 5Th September 2025 Inter Alia To Approve Appointment Of Secretarial Auditor For The Period Of 5 Years And Re-Appointment Of Director Who Is Retiring By Rotation.",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 inter alia to consider and approve Board meeting  Intimation to be held on 5th September 2025 inter alia to approve Appointment of Secretarial Auditor for the period of 5 years and re-appointment of Director who is retiring by rotation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c79973f6-d8ee-409d-9cab-04e0571c33ab.pdf",
            "news_date": "2025-08-28 18:11:02"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Disclosure of material event/information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c963552e-cd67-4e66-8067-6ec4d801f4c2.pdf",
            "news_date": "2025-08-22 14:29:10"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Court Convened Meeting",
            "caption": "Intimation Of Voting Results And Scrutinizers Report Of Tribunal Convened Equity Shareholders Meeting Held On 12Th August 2025 At 12.30 P.M.",
            "news_body": "Intimation of voting results and Scrutinizers Report of Tribunal Convened Equity Shareholders meeting held on 12th August 2025 at 12.30 P.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19478d11-6578-4120-8d05-ffc3c71cb319.pdf",
            "news_date": "2025-08-14 13:23:50"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Court Convened Meeting",
            "caption": "Intimation Of The Voting Results And Scrutinizers Report For The Tribunal Convened Unsecured Creditors Meeting Held On 12Th August 2025 At 11:00 A.M.",
            "news_body": "Intimation of the Voting results and Scrutinizers report for the Tribunal Convened Unsecured Creditors meeting held on 12th August 2025 at 12:30 P.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf2f3d2a-f8fa-4d2c-a894-8ce671e20d8f.pdf",
            "news_date": "2025-08-14 13:16:29"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 13 2025 for Shri JB Pharma Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=792111C5_7058_483A_BB8A_4049B5C1727D_180057.pdf",
            "news_date": "2025-08-13 18:01:01"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 12 2025 for Shri JB Pharma Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7C5041C5_1A1C_4454_9447_5B24E6C14239_115627.pdf",
            "news_date": "2025-08-13 11:56:36"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Court Convened Meeting",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting",
            "news_body": "Intimation of outcome of Tribunal Convened Meeting of Equity Shareholders of Mangalam Drugs and Organics Limited held on 12th August 2025 at 12:30 P.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31a21c9a-2656-4576-a739-8d39ab548c41.pdf",
            "news_date": "2025-08-12 19:20:12"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Court Convened Meeting",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting",
            "news_body": "Intimation of the outcome for the Tribunal Convened meeting of Unsecured Creditors of Mangalam Drugs and Organics Limited was held on 12th August 2025 at 11: 00A.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4ff814f-109e-486a-ab40-5d88bba7a40f.pdf",
            "news_date": "2025-08-12 19:12:09"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication in English Newspaper-Financial Express Mumbai edition and Marathi Newspaper- Loksatta for declaration of Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72e45ed3-08b5-4554-a75c-da3502efb38f.pdf",
            "news_date": "2025-08-08 15:04:56"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "news_id": "a185b26e-c01a-4492-977c-a1891785410f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18b7419f-f602-4a5d-9d1e-adaa40b02b91.pdf",
            "news_date": "2025-08-07 21:56:12",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18b7419f-f602-4a5d-9d1e-adaa40b02b91.pdf",
            "news_date": "2025-08-07 21:56:12"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "news_id": "23b5de9d-6953-4da0-995b-f0a2aa61a972",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c75f665e-125a-42a5-b368-94acc4d2071a.pdf",
            "news_date": "2025-08-07 21:54:53",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c75f665e-125a-42a5-b368-94acc4d2071a.pdf",
            "news_date": "2025-08-07 21:54:53"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August 2025 For The Unaudited Financial Results For The Quarter Ending June 2025",
            "news_body": "Intimation of Outcome of Board Meeting held on 7th August 2025 for the Unaudited financial Results for the Quarter ending June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af3cea16-b531-48d2-b7e0-f7d2eac6ab5e.pdf",
            "news_date": "2025-08-07 20:50:15"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of Board Meeting For Approval Of Unaudited Financial Results For 1St Quarter Ending Of 2025-26 To Be Held On 7Th August 2025 At 4:00 P.M.",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve Notice of Board Meeting for approval of Unaudited financial results for 1st Quarter ending of 2025-26 to be held on 7th August 2025 at 4:00 P.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0b96f3e-9124-4d36-9899-136485aca10c.pdf",
            "news_date": "2025-07-30 19:53:30"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Notice Of  Tribunal Convened Meeting Of Unsecured To Be Held On 12Th August 2025 At 11:00 A.M.",
            "news_body": "Intimation of Notice of Tribunal Convened Meeting of Unsecured Creditors to be held on 12th August 2025 at 11:00 A.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd183ae-e94a-4f84-a959-54c89327158b.pdf",
            "news_date": "2025-07-12 17:56:03"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Notice of Tribunal Convened Meeting for Equity shareholders and Unsecured Creditors to be held on 12th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9115b30-433b-483c-aa24-514bce3563b5.pdf",
            "news_date": "2025-07-12 16:23:02"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Court Convened Meeting",
            "caption": "Notice Of Tribunal Convened Meeting Of Shareholders To Be Held On 12Th August 2025 At 12:30 P.M.",
            "news_body": "Intimation of Tribunal Convened Meeting of Shareholders to be held on 12th August 2025 at 12:30 P.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5c27634-6dbf-4e62-9ca8-b93bf914f954.pdf",
            "news_date": "2025-07-12 16:01:33"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Submission of Certificate under Regulation 74(5) SEBI (DP) Regulations 2018 received from RTA-MUGF Intime India Private Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cba77eb9-3a8b-48e5-b373-da4c9ec19463.pdf",
            "news_date": "2025-07-09 18:11:17"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Amalgamation / Merger / Demerger",
            "caption": "Corporate Action-Updates on Amalgamation/ Merger / Demerger",
            "news_body": "Intimation on receipt of Certified True Copy of order passed by Honble National Company Law Tribunal Mumbai Bench (Honble Tribunal) directing the Company to convene a Meeting of the Equity Shareholders and Unsecured Creditors of the Company in the matter of Scheme of Merger by Absorption of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited with Mangalam Drugs and Organics Limited and their respective shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cd70e0a-f7e3-4b01-b389-7e53ce2fa842.pdf",
            "news_date": "2025-07-09 15:45:41"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading for the period ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7070afb7-2a82-436e-8bc2-62365ba80118.pdf",
            "news_date": "2025-06-27 17:06:50"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Submission of Annual Secretarial Compliance Report received from Practising Company Secretary - Ragini Chokshi & Co. for the period ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9e41e87-afa3-4d0e-a823-32b7d1058537.pdf",
            "news_date": "2025-05-30 18:41:49"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Revision of outcome",
            "caption": "Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 17Th May 2025 Inter- Alia To Approve Audited Financial Results For The Quarter And Year Ended 31St March 2025.",
            "news_body": "Revised outcome of Board Meeting held on 17th May 2025 inter-alia to approve Audited Financial Results for the quarter and year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cfa8a02-89e2-43a7-9947-c3c03bc9e42c.pdf",
            "news_date": "2025-05-30 15:14:45"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for Declaration of financial results for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20dc865b-de1f-49e2-8a87-cf5d758a941d.pdf",
            "news_date": "2025-05-19 17:07:09"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Outcome of board meeting held on 17th May 2025 for approval of Audited Financial Results for the quarter ended 31st March 2025",
            "news_id": "774c5d44-67b9-4531-8637-6b5afd70ff4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1d65f51-a469-4a58-8983-704c6555b157.pdf",
            "news_date": "2025-05-17 23:58:07",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Approval Of Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Outcome of board meeting held on 17th May 2025 for approval of Audited Financial Results for the quarter ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1d65f51-a469-4a58-8983-704c6555b157.pdf",
            "news_date": "2025-05-17 23:58:07"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 17Th May 2025 At 5:00 P.M. To Approve Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2025",
            "news_body": "Outcome of Board meeting held on 17th May 2025 at 5:00 p.m. to approve Audited Financial Results of the Company for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0260648-1a84-4a41-ab6e-567680b2869e.pdf",
            "news_date": "2025-05-17 22:28:45"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results(Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2025 inter alia to consider and approve Intimation of Board meeting to be held on 17th May 2025 inter-alia to approve Audited Financial Results(standalone and consolidated) for the quarter and year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604992ae-a713-427a-91b5-95e8e889a302.pdf",
            "news_date": "2025-05-14 21:16:29"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Outcome of Board meeting held on 11th April 2025 inter alia for approval of appointment of Chief Financial Officer (Key Managerial Personal) of the Company w.e.f. 11th April  2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1ac0929-dd45-42ae-ab85-5d44e1ef5570.pdf",
            "news_date": "2025-04-11 16:52:41"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 11Th April 2025 At 2:00 P.M.",
            "news_body": "Outcome of Board meeting held on Friday 11th April 2025 at 2:00 P.M. inter alia for approval of following Businesses:\r\nAppointment of Chief Financial Officer   Internal Auditor Cost Auditor of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d752f25a-d567-4f00-9384-2da38aed4eee.pdf",
            "news_date": "2025-04-11 16:44:37"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (Depositories Participants) Regulations 2018 received from MUFG Intime India Private Limited (previously Link Intime India Private Limited)-RTA on 5th April 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7941c7b6-ac0b-431b-b60a-f1b3dc25d0cb.pdf",
            "news_date": "2025-04-09 13:29:38"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Regulatory Update As Per Regulation 31(4) Of Substantial Acquisition Of Shares And Takeover Regulations 2011",
            "news_body": "Regulatory update as per Regulation 31(4) of Substantial Acquisition of shares and Takeover Regulations 2011",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae2d8b3-a030-4daf-b2ac-767e62a1cc9a.pdf",
            "news_date": "2025-04-07 17:49:10"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 11Th April 2025 To Approve Appointment Of Chief Financial Officer Of The Company W.E.F. 11Th April 2025",
            "news_body": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2025 inter alia to consider and approve Intimation of Board Meeting to be held on 11th April 2025 for approval of appointment of Chief Financial Officer of the Company w.e.f. 11th April 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ab679fc-3b30-4120-95e6-e3cca4dc355d.pdf",
            "news_date": "2025-04-04 16:36:00"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Chief Financial Officer (CFO)",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
            "news_body": "Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements)Regulations 2015 for acceptance of resignation tendered by Chief Financial Officer of the Company w.e.f. 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604e321e-e757-4adf-b2d1-075fbed3dc92.pdf",
            "news_date": "2025-03-29 16:02:51"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Board Meeting Held On 29Th March 2025 For Acceptance Of The Resignation Tendered By Chief Financial Officer Of The Company W.E.F. 31St March 2025",
            "news_body": "Outcome of Board meeting held on 29th March 2025 for acceptance of the resignation tendered by Chief Financial Officer of the Company w.e.f. 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=658098fd-aa11-403c-8e86-b1a16c3d0798.pdf",
            "news_date": "2025-03-29 15:56:51"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of trading window for the quarter and year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16366d08-ffe2-469e-952b-e9d2ffcf8217.pdf",
            "news_date": "2025-03-28 15:18:19"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 06 2025 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1EFB295B_67BE_4235_9167_D389A5C09A67_180449.pdf",
            "news_date": "2025-03-06 18:04:54"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Financials(PDF) for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b36fd93d-97be-4c44-8890-de4491d39c9a.pdf",
            "news_date": "2025-02-25 17:49:33"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Un-Audited Financial Results for the quarter ended 31st December  2024 declared in the Board Meeting held on 13th February 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=474ed256-8d48-4c77-b65b-4ad83d8aa45d.pdf",
            "news_date": "2025-02-15 14:14:41"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "Board meeting held on 13th February 2025 for declaration of Un-Audited Financial Results of the Company For the quarter ended 31st December 2024.",
            "news_id": "f99be743-324f-4771-93f2-0bfc70450add",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bb68bb-d8dc-41c9-b0f0-e3396753266e.pdf",
            "news_date": "2025-02-13 19:56:25",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "Board meeting held on 13th February 2025 for declaration of Un-Audited Financial Results of the Company For the quarter ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bb68bb-d8dc-41c9-b0f0-e3396753266e.pdf",
            "news_date": "2025-02-13 19:56:25"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "Declaration of Un-Audited Financial Results for the quarter ended 31st December 2024 in the Board meeting held on 13th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4790a114-4ff2-4268-ad72-442459048784.pdf",
            "news_date": "2025-02-13 19:51:23"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13Th February 2025 For Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2024",
            "news_body": "MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Intimation of Board meeting to be held on 13th February 2025 for approval of Un-audited Financial results of the Company for the quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8c7bcd9-f82f-4dc0-8c34-214e670a9070.pdf",
            "news_date": "2025-02-05 17:33:04"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 30 2025 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8F38072E_AFEC_413E_BD31_950B517F677C_100941.pdf",
            "news_date": "2025-01-31 10:09:50"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 18 2025 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D0130B71_E809_42D2_A9BA_2024CE0C27C6_173708.pdf",
            "news_date": "2025-01-18 17:37:19"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 of SEBI (Depositories and Participants) Regulations 2018 received from MUFG Intime India Private Limited  formerly known as Link Intime India Private Limited for the quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2926f89c-f119-47af-9d43-6b66d6cdae75.pdf",
            "news_date": "2025-01-17 15:05:51"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Regulation 30 Read With Schedule II Part A Of SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015",
            "news_body": "Update on Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding upgrade in CRISIL Rating Long Term BBB-/Stable and Short Term Rating- A3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a33d528e-9f0d-4e29-8eaa-7b506a1e2225.pdf",
            "news_date": "2025-01-16 14:50:48"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Update as per Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding upgrade in CRISIL Rating for Long Term as BBB-/Stable and for short Term Rating- Crisil A3.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6e0f7ce-1b16-4e49-a425-f346608cf8b0.pdf",
            "news_date": "2025-01-16 13:30:51"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 13 2025 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34D2F9ED_0484_4F3E_9F50_A0A1EA788719_101629.pdf",
            "news_date": "2025-01-14 10:16:43"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window for the  quarter ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86cab0fb-a68c-414f-98cc-e07f06f77e5a.pdf",
            "news_date": "2024-12-30 16:06:03"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Announcement as per Regulation 30 (Listing Obligations and Disclosure Requirement) Regulations, 2015 w.r.t. Appointment of Company Secretary, Compliance Officer and Key Managerial Personnel of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88e10842-73db-4a7b-ad51-80b027cf8ab2.pdf",
            "news_date": "2024-12-04 17:57:12"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Board meeting held on 8th July, 2024 for approval of appointment of Ms. Anuradha Pandey (M. No. ACS-72902) Company Secretary and Compliance Officer and Key Managerial Personnel of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=113b5ee4-35d2-49f7-b192-8870f7b31bd5.pdf",
            "news_date": "2024-12-04 17:14:18"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Board meeting dated 8th July , 2024 approved the appointment of Ms. Anuradha Pandey, (M.No. A72902) Company Secretary and Compliance Officer of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7b2103b-9868-4ead-9b62-0024ab43273d.pdf",
            "news_date": "2024-12-04 11:47:09"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2024 for Shree Kishoriju Trading & Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CCA1C01D_3357_4591_9165_4A4FE41637C5_192037.pdf",
            "news_date": "2024-11-18 19:20:41"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Un-Audited Standalone and Consolidated Financial results for the quarter ended 30th September 2024 declared on Board meeting held on 14th November, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=523ed0fc-8c8b-424d-b9f2-de0627a91342.pdf",
            "news_date": "2024-11-15 19:16:52"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "Board meeting held on 14 th November 2024 for declaration of Un-audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2024",
            "news_id": "012565a3-9c2e-4cb3-a459-0859ab382045",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6034a3e2-b62a-4432-8705-7e88ba896e1b.pdf",
            "news_date": "2024-11-14 19:15:44",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "Board meeting held on 14 th November 2024 for declaration of Un-audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6034a3e2-b62a-4432-8705-7e88ba896e1b.pdf",
            "news_date": "2024-11-14 19:15:44"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Held On 14Th November 2024 For Declaration Of Un-Audited Satandalone And Consolidated Financial Results For The Quareter Ended 30Th September, 2024",
            "news_body": "Board meeting held on 14th November 2024 for declaration of Un-Audited Satandalone and Consolidated Financial Results for the quareter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23f6c0bc-6695-4500-9fab-889112a0819f.pdf",
            "news_date": "2024-11-14 19:10:23"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th September, 2024",
            "news_body": "MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Un-Audited Financial Results of the Company for the Quarter ended 30th September, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83b7adcc-b5f1-46cc-a5e9-4c5966b02f96.pdf",
            "news_date": "2024-11-08 14:41:59"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 07, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=055AA853_EFCE_43C5_8098_A10B8D62733F_102810.pdf",
            "news_date": "2024-11-08 10:28:17"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 as received from Link Intime India Private Limited for the quarter ended 30th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34769aa7-3a09-4a31-9ba6-066f206452e5.pdf",
            "news_date": "2024-10-17 13:32:59"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Submission of Compliance Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)Regulations, 2015  as received from RTA- Link Intime India Private Limited as on 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa671426-b2ef-4920-a99a-2e9f173e4965.pdf",
            "news_date": "2024-10-14 13:18:16"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30(Listing Obligationa And Disclosure Requirement) Regarding The Companies Participation In Cphi Event Held In Milan, Italy",
            "news_body": "Company is excited to announce its participation in CPhI Event held in Milan, Italy From October 8th to October 10th, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a2b5a0c-caeb-47e8-8285-d32ad2faf4eb.pdf",
            "news_date": "2024-10-11 12:39:20"
        },
        {
            "co_code": 20249,
            "bse_code": 532637,
            "isin": "INE584F01014",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015 Regarding Judgement Passed For Case No. 8766/06 By Vapi Additional Chief Judicial Magistrate Court, Vapi, District Valsad, Gujarat",
            "news_body": "Being final order passed by Vapi Additional Chief Judicial Magistrate Court, Vapi, District Valsad, Gujarat for the Case No. 8766/06. Attachment of the Final order copy is in Gujarati Language, translation for which is given for your reference. Kindly take it on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4c57d67-4e5d-4794-a390-9fb8eddd4110.pdf",
            "news_date": "2024-10-08 16:58:11"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Approval of Standalone and consolidated Un-audited financial results of the Company for the quarter ended 30.06.2024",
            "news_id": "617bcffb-2072-435f-a251-09c45076dfd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b3fe7e-fb3f-4219-879f-12cdd9551bf4.pdf",
            "news_date": "2024-08-13 19:53:05",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31 2024 AND OTHER AGENDA ITEMS",
            "news_body": "FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31 2024 AND OTHER AGENDA ITEMS",
            "news_id": "0609cd90-1b45-409d-9f21-5d631a6217b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b67c964b-14ae-4db7-91b6-0a7d4034c306.pdf",
            "news_date": "2024-05-21 19:35:24",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2023",
            "news_body": "Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023",
            "news_id": "c646c0ec-3c34-4393-a311-bbdf37d03be3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e48f3e49-744e-4d33-bec9-6186fcc7da9b.pdf",
            "news_date": "2024-02-13 19:39:04",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of The Revised Consolidated Statement Of Unaudited Financial Results, Statement Of Assets And Liabilities And Statement Of Cash Flow For The Period Ended September 30, 2023",
            "news_body": "Submission of Revised Consolidated Statement of Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement for the period ended 30.09.2023",
            "news_id": "8f697b06-0aac-4c7f-8856-84a4f34e59e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7632df7b-d9b0-4b8d-a019-d2336e31ab22.pdf",
            "news_date": "2024-01-16 20:32:30",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Consolidated Cash Flow Statement For The Period Ended 30Th September 2023",
            "news_body": "Submission of Consolidated Cash Flow Statement for the period ended 30th September 2023",
            "news_id": "83103e0c-e2a3-4cf1-8705-56efbd431576",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e05d7c0-7229-40f4-b7f6-0bdab98f628c.pdf",
            "news_date": "2024-01-04 14:31:34",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30.09.2023",
            "news_body": "Standalone and consolidated financial results for the period ended 30.09.2023",
            "news_id": "e7ee4daa-0e66-43a4-82d7-bc89933e8d57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=887172ff-4ed7-43ea-9736-2f2c8092d30a.pdf",
            "news_date": "2023-11-08 20:02:49",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2023",
            "news_body": "Unaudited financial results for the quarter ended June 30 2023 along with the Limited review report on the same.",
            "news_id": "91f22fe7-ee3a-4c55-bb50-7821aecba6f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=745d454e-7d7f-4539-8146-0ef1ce0f32eb.pdf",
            "news_date": "2023-08-10 17:50:11",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS FOR THE FINANCIAL YEAR ENDED 31ST MARCH 2023",
            "news_body": "With respect to the captioned subject and mentioned reference, we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Tuesday, May 30, 2023 has inter-alia transacted the following business:  The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2023 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.)",
            "news_id": "c3e15c86-5e94-4ad8-a425-6a745f44a573",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01e50800-ba58-4695-a531-f243621db8dd.pdf",
            "news_date": "2023-05-30 18:56:58",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results- For The Period Ended DECEMBER 31, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., February 13, 2023 inter-alia transacted the following business:1. Considered & approved the Un-Audited Financial Results for the period ended December 31st, 2022 along with the Limited Review Report on the un-audited results pursuant to Regulation 33 of the Listing Regulations;",
            "news_id": "5ee3a9ba-5f9c-4b97-a33a-a8e2e363f8bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3296a7c8-70b3-4ae8-9719-3b8baa2d3ab5.pdf",
            "news_date": "2023-02-13 19:06:15",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing      Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended September 30, 2022.",
            "news_id": "9bcd59ed-4afb-4b70-960b-56f104ee7f32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6dc4796-328d-4439-a901-338b62e85262.pdf",
            "news_date": "2022-11-22 13:47:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Friday, November 11, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 11, 2022 transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the period ended September 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations;",
            "news_id": "873adae9-5332-4771-85f4-d48f428ab62a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4cb5853-87a6-4c5f-be84-498a47988f73.pdf",
            "news_date": "2022-11-11 15:55:30",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Amended Policy On Criteria For Determining Materiality Of Events As Per Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulations, 2015 (Annexure C).",
            "news_body": "Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).",
            "news_id": "da074a85-cc23-40ed-a22d-ad3ef0310c28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef4aba85-ca35-4276-9869-0d9c45a70567.pdf",
            "news_date": "2022-08-05 17:26:01",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR>",
            "news_id": "a82c18db-c406-4f79-9b5c-a5cf4a2449f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26cb6f76-509e-4808-95e7-350f9471c5db.pdf",
            "news_date": "2022-08-05 17:13:01",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR>",
            "news_id": "4adf3519-4094-457d-8aed-d1c376032850",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f48f83b-c5f5-4195-b402-82e5fbaf96d5.pdf",
            "news_date": "2022-08-05 17:12:10",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, August 5, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR> 2. Amended Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated persons and immediate relatives of Designated persons in the securities of the company as per Regulation 9 of SEBI (Prohibition of Insider Trading), Regulations, 2015; (Annexure B)<BR> 3. Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).<BR>",
            "news_id": "329eeb88-0d93-484c-ab30-9c1e2013e2c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e415ab2-f6be-4f4d-a5ec-c2ff2ed54b88.pdf",
            "news_date": "2022-08-05 17:05:15",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended March 31, 2022. Kindly take the above information on your records.",
            "news_id": "df8b71e2-4e23-4b56-9fb5-7083f3bf88ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ab40aaf-012c-4b47-9810-399498f48f5b.pdf",
            "news_date": "2022-06-06 17:05:02",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "We Are Pleased To Inform That The Board Of Directors Of The Company, In Their Meeting Held Today I.E., Thursday, May 26, 2022 Has Inter-Alia Transacted The Following Business:The Audited Financial Results (Standalone) For The Quarter And Financial Year Ended March 31, 2022 Pursuant To Regulation 33 Of The SEBI LODR Regulations. (A Copy Of The Said Results, Notes Thereto And Auditor'S Report Is Annexed Hereto And Marked As Annexure I.)",
            "news_body": "we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business:The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.)",
            "news_id": "bee5e2ae-0e52-47ff-8e6a-2b6afaa428ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6950bbb2-0a8e-4bec-b5ea-07414de35e6a.pdf",
            "news_date": "2022-05-26 19:02:51",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, May 26, 2022",
            "news_body": "we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business:The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexures)",
            "news_id": "fd093370-ca39-44f2-9504-bba90106212a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77d63101-9312-4d53-9905-0239658d0973.pdf",
            "news_date": "2022-05-26 18:59:59",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Un-Audited Financial Results for the quarter and nine months ended December 31, 2021",
            "news_id": "b6055152-4154-4bf8-82b5-45362cb7e2ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78247bfb-8648-476e-97de-e0a5e04c62bd.pdf",
            "news_date": "2022-02-04 17:18:14",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, February 4, 2022",
            "news_body": "Outcome of Board Meeting held on Friday, February 4, 2022",
            "news_id": "65f88b4b-7bf9-4080-957e-a0bb70704d8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b3c17d1-f029-4e8c-93c7-5b13ec0cc36b.pdf",
            "news_date": "2022-02-04 17:12:26",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions Under Regulation 23(9) Of The SEBI Listing Regulations, 2015 For The Half Year Ended September 30, 2021.",
            "news_body": "Related Party Transactions under Regulation 23(9) of the SEBI Listing Regulations, 2015 for the half year ended September 30, 2021.",
            "news_id": "731eaa76-51b6-4fc2-8491-962dac0abd8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1917d218-3326-415e-808a-c037e36cb054.pdf",
            "news_date": "2021-12-10 12:24:29",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021.",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021 inter-alia considered & approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2021 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Limited Review Report of the Auditor is enclosed for your records.",
            "news_id": "b655c693-42e3-48f3-8a79-563c8208d676",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eeb4bad7-8a6d-4906-bbc2-d9ea288c421a.pdf",
            "news_date": "2021-11-12 16:53:45",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Un-audited Financial Results for the quarter ended June 30, 2021.",
            "news_id": "8b224d69-3786-434d-b8ef-6c6ab0d0caca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1657a51-3f64-47f6-a5bc-74ae707fdbd4.pdf",
            "news_date": "2021-08-12 17:51:08",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, August 12, 2021.",
            "news_body": "Outcome of Board Meeting held on Thursday, August 12, 2021.",
            "news_id": "b33184cf-81f4-4291-b9b3-7f1d846873b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=818d685e-d919-443b-a38a-b32c1e32a52c.pdf",
            "news_date": "2021-08-12 17:46:17",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed<BR> herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the year ended March 31, 2021.",
            "news_id": "8f905d76-5606-4e51-abba-0a001044cb90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8905f5ac-6715-45da-86a6-fbe1d41fe840.pdf",
            "news_date": "2021-06-11 14:44:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone) For The Quarter And Year Ended March 31, 2021.",
            "news_body": "Audited Financial Results (Standalone) for the quarter and year ended March 31, 2021.",
            "news_id": "b122e47a-af27-4360-9f34-771773f2aa4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=971db30b-cf9b-474f-9a79-34c483f7753a.pdf",
            "news_date": "2021-05-20 16:39:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, May 20, 2021",
            "news_body": "Outcome of the Board Meeting held on Thursday, May 20, 2021",
            "news_id": "335b8343-83c9-4756-9b5d-cc0078b97073",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b84018dc-9052-4825-a838-65291869db7a.pdf",
            "news_date": "2021-05-20 16:33:07",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}